Quick Answer
Medirom Healthcare Technologies Inc. reported Total Revenue of $8.30 billion for fiscal year 2024.
Medirom Healthcare Technologies Inc. — Key Financials by Year
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Total Revenue | $8.30B +21.5% |
$6.83B -1.8% |
$6.95B +28.5% |
$5.41B +61.9% |
$3.34B -14.5% |
$3.91B |
| Revenue (ASC 606) | $8.30B +21.5% |
$6.83B -1.8% |
$6.95B +28.5% |
$5.41B +61.9% |
$3.34B -14.5% |
$3.91B |
| Net Income | $148.76M +28.9% |
$115.40M -22.5% |
$148.97M +115.0% |
-$990.73M -83.8% |
-$539.17M -3210.3% |
$17.34M |
| Diluted EPS | $28.52 +27.7% |
$22.34 -18.0% |
$27.23 +113.4% |
-$203.13 -51.6% |
-$133.97 -3399.8% |
$4.06 |
| Total Assets | $8.09B +18.1% |
$6.85B +1.5% |
$6.75B +17.3% |
$5.75B +0.7% |
$5.71B +20.1% |
$4.76B |
| Cash and Equivalents | $2.09M -98.0% |
$106.35M -82.4% |
$605.45M +63.4% |
$370.62M -74.3% |
$1.44B +180.3% |
$513.62M |
| Long-Term Debt | $764.20M -27.3% |
$1.05B -8.6% |
$1.15B +54.0% |
$746.59M +11.7% |
$668.38M +344.0% |
$150.53M |
| Stockholders Equity | $933.27M +342.6% |
$210.88M +455.1% |
-$59.38M +71.5% |
-$208.34M -142.4% |
$491.26M -18.1% |
$600.06M +610.4% |
| Operating Income | -$18.10M +95.4% |
-$391.58M -503.8% |
$96.97M +120.6% |
-$470.59M +36.9% |
-$746.09M -2272.0% |
$34.35M |
| Shares Outstanding | 7.90M | — | — | — | — | — |
- Medirom Healthcare Technologies Inc. reported Total Revenue of $8.30 billion for fiscal year 2024.
- Medirom Healthcare Technologies Inc. showed an increase of +21.5% in Total Revenue compared to the prior fiscal year.
- Medirom Healthcare Technologies Inc. reported Revenue (ASC 606) of $8.30 billion for fiscal year 2024.
- Medirom Healthcare Technologies Inc. showed an increase of +21.5% in Revenue (ASC 606) compared to the prior fiscal year.
- Medirom Healthcare Technologies Inc. reported Net Income of $148.76 million for fiscal year 2024.
- Medirom Healthcare Technologies Inc. showed an increase of +28.9% in Net Income compared to the prior fiscal year.
- Medirom Healthcare Technologies Inc. reported Diluted EPS of $28.52 per share for fiscal year 2024.
- Medirom Healthcare Technologies Inc. showed an increase of +27.7% in Diluted EPS compared to the prior fiscal year.
- Medirom Healthcare Technologies Inc. reported Total Assets of $8.09 billion for fiscal year 2024.
- Medirom Healthcare Technologies Inc. showed an increase of +18.1% in Total Assets compared to the prior fiscal year.
- Medirom Healthcare Technologies Inc. reported Cash and Equivalents of $2.09 million for fiscal year 2024.
- Medirom Healthcare Technologies Inc. showed a decrease of -98.0% in Cash and Equivalents compared to the prior fiscal year.
- Medirom Healthcare Technologies Inc. reported Long-Term Debt of $764.20 million for fiscal year 2024.
- Medirom Healthcare Technologies Inc. showed a decrease of -27.3% in Long-Term Debt compared to the prior fiscal year.
- Medirom Healthcare Technologies Inc. reported Stockholders Equity of $933.27 million for fiscal year 2024.
- Medirom Healthcare Technologies Inc. showed an increase of +342.6% in Stockholders Equity compared to the prior fiscal year.
- Medirom Healthcare Technologies Inc. reported Operating Income of -$18.10 million for fiscal year 2024.
- Medirom Healthcare Technologies Inc. showed an increase of +95.4% in Operating Income compared to the prior fiscal year.
- Medirom Healthcare Technologies Inc. reported Shares Outstanding of 7.90 million shares for fiscal year 2024.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: